“Is it a bubble?”
This is an essential question that investors in any fast-rising market or sharply rallying asset should ask themselves. Unfortunately, it’s much easier to answer this question in retrospect; one could argue that, if a bubble were visible from up close, it would lose its appeal to investors — and burst as a result.
—Sponsored Link— Top 3 California Pot Stocks To Watch For The Biggest Gains
On January 1, California will completely legalize cannabis for medical and recreational use — promising to spark a $20.2 BILLION industry in the Golden State alone. By getting in on the ground floor of this exceptional opportunity, you could have the chance to pocket life-changing windfalls thanks to this historic event. And one pot stock expert has his sights set on three stocks he expects to skyrocket following this crucial announcement. Get the details here.
Regardless of whether warning signs are visible, an unraveling bubble is a difficult pill to swallow. So, if asking the right questions can help prevent a bubble from getting bigger, we should keep doing so. And if it’s not a bubble, even better; besides a missed opportunity, not much will be lost.
Best Medical Stocks To Own For 2018: Guess?, Inc.(GES)
- [By Peter Graham]
A long term performance chart shows Urban Outfitters along with other specialty fashion retailers likelarge capThe Gap Incs (NYSE: GPS) and small capsAbercrombie & Fitch Co (NYSE: ANF) and Guess?, Inc (NYSE: GES) all largelydrifting lower over the past few years albeit there have been dips and peaks where traders could profit:
- [By Peter Graham]
A long term performance chart shows mid cap Urban Outfitters along with The Gap Incs (NYSE: GPS) back at break even levels for long term investors whilewhile small capsAbercrombie & Fitch Co (NYSE: ANF) and Guess?, Inc (NYSE: GES) haveseverely underperformed:
- [By Chris Lange]
Guess, Inc. (NYSE: GES) reported fiscal third-quarter financial results after markets closed on Wednesday. The company said that it had $0.11 in earnings per share (EPS) and $536.3 million in revenue. Thomson Reuters had consensus estimates that called for $0.14 in EPS and $548.37 million in revenue. The same period from last year had $0.15 in EPS and $520.96 million in revenue.
- [By Lisa Levin]
Guess?, Inc. (NYSE: GES) was down, falling around 13 percent to $15.65. Guess? reported in-line earnings for its third quarter, while sales missed estimates. U.S. comps were down 10 percent.
Best Medical Stocks To Own For 2018: Curis, Inc.(CRIS)
- [By Ben Levisohn]
Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).
- [By Alex McGuire]
These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…
Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%
As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.
- [By Paul Ausick]
Curis Inc. (NASDAQ: CRIS) matched a 52-week low of $0.88 set Friday. The 52-week high is $3.48. Volume was about 4 million, four times the daily average of around 1 million. The drugmaker had no specific news Monday.
Best Medical Stocks To Own For 2018: WGL Holdings Inc(WGL)
- [By Shauna O’Brien]
Brean Capital reported on Friday that it has upgraded natural gas utility company WGL Holdings Inc (WGL).
The firm has raised its rating on WGL from “Hold” to “Buy,” and has given the company a $46 price target. This price target suggests a 12% increase from the stock’s current price of $40.62. The upgrade was primarily based on valuation and future investment opportunities.
“Like many utilities in the gas LDC space, the shares of WGL Holdings have come off recent highs and are now trading at a level we consider attractive,” analyst Michael Gaugler comments. “Beyond valuation, we consider the recent announcement of conditional approval of Dominion’s Cove Point facility for LNG export as a positive development in terms of future investment opportunities, given the company’s one-third interest in the Commonwealth Pipeline project, which we believe will be revisited due to future increased demand.”
WGL Holdings shares were mostly flat during pre-market trading Friday. The stock has been mostly flat YTD.
Best Medical Stocks To Own For 2018: SPDR Dow Jones Industrial Average ETF (DIA)
- [By WWW.MONEYSHOW.COM]
A good way to play this is by buying the SPDR Dow Jones Industrial Average ETF (DIA), which tracks the Dow Industrials. We add that the SPDR S&P 500 ETF Trust (SPY) would be a good bet as well.
- [By Elizabeth Balboa]
The SPDR Dow Jones Industrial Average ETF (NYSE: DIA) and the SPDR S&P 500 ETF Trust (NYSE: SPY) plunged 1.2 percent on the news, although it's worth noting that the markets had traded near these values Wednesday before riding a Thursday rally.
- [By WWW.MONEYSHOW.COM]
An easy way to profit from this bull market is to buy the ETFs that track these major averages – the SPDR Dow Jones Industrial Average ETF (DIA) and iShares Dow Jones Transportation Average ETF (IYT).
Best Medical Stocks To Own For 2018: Catalyst Pharmaceuticals, Inc.(CPRX)
- [By William Romov]
Before we show you our pick, here are the top 10 penny stocks to watch this week
Penny Stock Current Share Price Nov. 27-Dec. 1 Gain (as of Dec. 1)
Pyxis Tankers Inc. (Nasdaq: PXS) $4.10 122.83%
Ohr Pharmaceuticals Inc. (Nasdaq: OHRP) $1.28 68.42%
Cerecor Inc. (Nasdaq: CERC) $1.74 47.46%
Proteostasis Therapeutics Inc. (Nasdaq: PTI) $2.52 37.71%
UT Starcom Holdings Corp. (Nasdaq: UTSI) $5.20 37.20%
WMIH Corp. (Nasdaq: WMIH) $0.96 33.46%
PhaseRx Inc. (Nasdaq: PZRX) $0.90 30.29%
Bellerophon Therapeutics Inc. (Nasdaq: BLPH) $2.04 29.94%
EV Energy Partners LP (Nasdaq: EVEP) $0.86 27.76%
Catalyst Pharmaceuticals Inc. (Nasdaq: CPRX) $4.40 25.71%
FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, its completely free
- [By Lisa Levin]
Shares of Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got a boost, shooting up 32 percent to $1.54 after the company reported positive data from investigator-sponsored trial of Firdapse.